CWBR — CohBar Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $1.19m
- -$11.12m
Annual income statement for CohBar, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 15.3 | 12.6 | 15.5 | 15.4 | 12.4 |
Operating Profit | -15.3 | -12.6 | -15.5 | -15.4 | -12.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -15.7 | -13 | -16.3 | -15.5 | -12.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -15.7 | -13 | -16.3 | -15.5 | -12.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -15.7 | -13 | -16.3 | -15.5 | -12.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -15.7 | -13 | -16.3 | -15.5 | -12.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -11.4 | -9.14 | -8.59 | -6.97 | -4.2 |